| 000 | 01845 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517161719.0 | ||
| 264 | 0 | _c20180419 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2017.06.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Ravenhorst, Mariëtte B | |
| 245 | 0 | 0 |
_aAdolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination. _h[electronic resource] |
| 260 |
_bVaccine _c08 2017 |
||
| 300 |
_a4753-4760 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aComplement System Proteins |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
| 650 | 0 | 4 |
_aNeisseria meningitidis _ximmunology |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup Y _ximmunology |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSerogroup |
| 650 | 0 | 4 | _aSerum Bactericidal Antibody Assay |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 700 | 1 | _avan der Klis, Fiona R M | |
| 700 | 1 | _avan Rooijen, Debbie M | |
| 700 | 1 | _aSanders, Elisabeth A M | |
| 700 | 1 | _aBerbers, Guy A M | |
| 773 | 0 |
_tVaccine _gvol. 35 _gno. 36 _gp. 4753-4760 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2017.06.007 _zAvailable from publisher's website |
| 999 |
_c27309155 _d27309155 |
||